Thing, Mira
Werge, Mikkel Parsberg
Kimer, Nina
Hetland, Liv Eline
Rashu, Elias Badal
Nabilou, Puria
Junker, Anders Ellekaer
Galsgaard, Elisabeth Douglas
Bendtsen, Flemming
Laupsa-Borge, Johnny
McCann, Adrian
Gluud, Lise Lotte
Funding for this research was provided by:
Copenhagen University
Article History
Received: 8 November 2023
Accepted: 5 January 2024
First Online: 23 January 2024
Declarations
:
: The research was approved by The Regional Committee on Health Research Ethics, the capital region, Denmark (H-17029039). Informed consent was obtained from all participants.
: Not applicable.
: Author Elisabeth Douglas Galsgaard is employed at Novo Nordisk and author Adrian McCann and Johnny Laupsa-Borge are employed at Bevital AS. Author Mira Thing, Mikkel Parsberg Werge, Nina Kimer, Liv Eline Hetland, Elias Badal Rashu, Puria Nabilou, Anders Ellekær Junker and Flemming Bendtsen declare that they have no conflict of interest. Author Lise Lotte Gluud has received speaker honorarium from Norgine, Astra Zeneca, Sobi, Alexion and Novo Nordisk, consultant honorarium from Pfizer, Becton, Dickinson and Novo Nordisk and research funding from Alexion, Gilead Sciences and Novo Nordisk.